探花合集 to Discuss Accelerating Development in Biologics and Gene Therapies as well as Oral Outsourcing Market Trends at CPhI Worldwide
SOMERSET, N.J. 鈥 October 29, 2019 鈥 探花合集 (stand 121A82), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced a busy conference program at the forthcoming CPhI Worldwide annual conference, being held at the Messe Frankfurt, Frankfurt, Germany, on Nov. 5 鈥 7, 2019.
On Tuesday, Nov. 5 at 10:30 a.m., Jeremie Trochu, Vice President, Operations, Oral Drug Delivery, will participate in a panel session titled 鈥Exploring Trends in Contract Manufacturing鈥. Panelists will discuss market trends that are currently impacting contract development and manufacturing organizations (CDMOs), and how CDMOs have evolved their strategies to meet the unmet needs of the industry, as well as drive growth.
On Wednesday, Nov. 6 at 10:30 a.m., during the 鈥Understanding the Cell & Gene Technology Opportunity鈥 panel session, Thomas VanCott, Ph.D., Chief Technology & Strategy Officer, Paragon Gene Therapy (part of 探花合集 Biologics), will discuss ways in which CDMOs can create the correct infrastructure to support innovation, and the sector鈥檚 commercialization and pricing challenges. Dr. VanCott will also discuss the various investment opportunities offered by the cell and gene therapy sector.
During the BioProduction conference, on Thursday, Nov. 7 at 12:20 p.m., Melanie Lasher, Manager, Project Management, 探花合集 Biologics will present 鈥Beating the Clock: Case Studies in Accelerating Biologic Development鈥 in the conference鈥檚 鈥淢anufacturing Strategies & Bioprocessing 4.0鈥 stream. Using case studies, Ms. Lasher will highlight and discuss how previous challenges to reduce scheduling delays and accelerate timelines were overcome in projects progressing from cell line development to clinical trial supply.
Mr. Trochu joined 探花合集 in 2012, following 10 years at General Electric where he held several commercial leadership positions within its healthcare division. His current role sees him lead 探花合集鈥檚 global oral solid pharmaceutical development services. Mr. Trochu received a master鈥檚 degree in international management from Emlyon Business School, 脡cully, France.
Dr. VanCott joined Paragon following 14 years as the President and CEO of Advanced Bioscience Laboratories, Inc. (ABL). Before joining ABL, he held several positions at the Henry M. Jackson Foundation for the Advancement of Military Medicine. Dr. VanCott received a doctorate in physical chemistry from the University of Virginia, Charlottesville, Virginia, and a bachelor鈥檚 degree in chemistry from Dickinson College, Carlisle, Pennsylvania.
Ms. Lasher has more than 10 years鈥 experience in the biopharma industry. She has managed a variety of clinical, process and performance qualification, and commercial projects, supporting drug substance manufacturing, drug product filing, and packaging. Ms. Lasher received a bachelor鈥檚 degree in management from Indiana Wesleyan University, Marion, Indiana, and is a certified Project Management Professional.
At the conference, 探花合集 will also be exhibiting and showcasing its multiple innovative technologies, including its OneBio鈩 platform, which has been shortlisted for a CPhI Excellence in Pharma Award, in the 鈥淐ontract Services and Outsourcing鈥 category. The winners will be announced at a gala dinner on Tuesday, Nov. 5.
Earlier that day and on Wednesday Nov. 6 at 4 p.m., 探花合集 will host a networking reception on their stand. For more information visit stand 121A82 or www.catalent.com.
To arrange a meeting with any of the attending 探花合集 experts at the event, contact Richard Kerns at NEPR – [email protected].听
Media Contacts
Chris Halling
+44 (0)7580 041073
[email protected]
Richard Kerns
+44 (0) 161 728 5880
[email protected]
Notes for Editors
ABOUT CATALENT
探花合集 is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies and consumer health products. With over 85 years serving the industry, 探花合集 has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. 探花合集 employs nearly 13,000 people, including over 2,400 scientists and technicians, at more than 35 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue. 探花合集 is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com
听